Ligand selectivity among the dopamine and serotonin transporters specified by the forward binding reactions

Molecular Pharmacology

Volumn 88, Issue 1, 2015, Pages 12-18

  Hasenhuetl, Peter S ^a   Schicker, Klaus ^a   Koenig, Xaver ^a   Li, Yang ^a   Sarker, Subhodeep ^a   Stockner, Thomas ^a   Sucic, Sonja ^a   Sitte, Harald H ^a   Freissmuth, Michael ^a   Sandtner, Walter ^a,b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VETERINARY MEDICINE   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; DESIPRAMINE; DOPAMINE TRANSPORTER; METHYLPHENIDATE; RADIOLIGAND; SEROTONIN TRANSPORTER; NEUROTRANSMITTER UPTAKE INHIBITOR; SLC6A4 PROTEIN, HUMAN;

ACCURACY; ARTICLE; ASSOCIATION RATE CONSTANT; BINDING AFFINITY; BINDING KINETICS; BINDING SITE; COMPETITIVE INHIBITION; DISSOCIATION RATE CONSTANT; HEK293 CELL LINE; HUMAN; HUMAN CELL; PATCH CLAMP TECHNIQUE; PRIORITY JOURNAL; PROTEIN BINDING; SITE DIRECTED MUTAGENESIS; STEADY STATE; CHEMISTRY; METABOLISM; PROCEDURES;

BINDING SITES; COCAINE; DESIPRAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; HEK293 CELLS; HUMANS; METHYLPHENIDATE; NEUROTRANSMITTER UPTAKE INHIBITORS; PATCH-CLAMP TECHNIQUES; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 84938871402     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.115.099036     Document Type: Article

References (22)

1. Andersen J, Stuhr-Hansen N, Zachariassen LG, Koldsø H, Schiøtt B, Strømgaard K, and Kristensen AS (2014) Molecular basis for selective serotonin reuptake inhibition by the antidepressant agent fluoxetine (Prozac). Mol Pharmacol 85:703-714.
2. Andersen J, Stuhr-Hansen N, Zachariassen L, Toubro S, Hansen SM, Eildal JN, Bond AD, Bøgesø KP, Bang-Andersen B, and Kristensen AS et al. (2011) Molecular determinants for selective recognition of antidepressants in the human serotonin and norepinephrine transporters. Proc Natl Acad Sci USA 108:12137-12142.
3. Bulling S, Schicker K, Zhang YW, Steinkellner T, Stockner T, Gruber CW, Boehm S, Freissmuth M, Rudnick G, and Sitte HH et al. (2012) The mechanistic basis for noncompetitive ibogaine inhibition of serotonin and dopamine transporters. J Biol Chem 287:18524-18534.
4. Copeland RA, Pompliano DL, and Meek TD (2006) Drug-target residence time and its implications for lead optimization. Nat Rev Drug Discov 5:730-739.
5. Erreger K, Grewer C, Javitch JA, and Galli A (2008) Currents in response to rapid concentration jumps of amphetamine uncover novel aspects of human dopamine transporter function. J Neurosci 28:976-989.
6. Forrest LR, Zhang YW, Jacobs MT, Gesmonde J, Xie L, Honig BH, and Rudnick G (2008) Mechanism for alternating access in neurotransmitter transporters. Proc Natl Acad Sci USA 105:10338-10343.
7. Henry LK, Field JR, Adkins EM, Parnas ML, Vaughan RA, Zou MF, Newman AH, and Blakely RD (2006) Tyr-95 and Ile-172 in transmembrane segments 1 and 3 of human serotonin transporters interact to establish high affinity recognition of antidepressants. J Biol Chem 281:2012-2023.
8. Hyman SE (2014) Revitalizing psychiatric therapeutics. Neuropsychopharmacology 39:220-229.
9. Jardetzky O (1966) Simple allosteric model for membrane pumps. Nature 211:969-970.
10. Krishnamurthy H and Gouaux E (2012) X-ray structures of LeuT in substrate-free outward-open and apo inward-open states. Nature 481:469-474.
11. Kristensen AS, Andersen J, Jørgensen TN, Sørensen L, Eriksen J, Loland CJ, Strømgaard K, and Gether U (2011) SLC6 neurotransmitter transporters: structure, function, and regulation. Pharmacol Rev 63:585-640.
12. Pan AC, Borhani DW, Dror RO, and Shaw DE (2013) Molecular determinants of drug-receptor binding kinetics. Drug Discov Today 18:667-673.
13. Penmatsa A, Wang KH, and Gouaux E (2013) X-ray structure of dopamine transporter elucidates antidepressant mechanism. Nature 503:85-90.
14. Sarker S, Weissensteiner R, Steiner I, Sitte HH, Ecker GF, Freissmuth M, and Sucic S (2010) The high-affinity binding site for tricyclic antidepressants resides in the outer vestibule of the serotonin transporter. Mol Pharmacol 78:1026-1035.
15. Schicker K, Uzelac Z, Gesmonde J, Bulling S, Stockner T, Freissmuth M, Boehm S, Rudnick G, Sitte HH, and Sandtner W (2012) Unifying concept of serotonin transporter-associated currents. J Biol Chem 287:438-445.
16. Severinsen K, Koldsø H, Thorup KA, Schjøth-Eskesen C, Møller PT, Wiborg O, Jensen HH, Sinning S, and Schiøtt B (2014) Binding of mazindol and analogs to the human serotonin and dopamine transporters. Mol Pharmacol 85:208-217.
17. Singh SK, Yamashita A, and Gouaux E (2007) Antidepressant binding site in a bacterial homologue of neurotransmitter transporters. Nature 448:952-956.
18. Sucic S, Dallinger S, Zdrazil B, Weissensteiner R, Jørgensen TN, Holy M, Kudlacek O, Seidel S, Cha JH, and Gether U et al. (2010) The N terminus of monoamine transporters is a lever required for the action of amphetamines. J Biol Chem 285:10924-10938.
19. Tatsumi M, Groshan K, Blakely RD, and Richelson E (1997) Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol 340:249-258.
20. Vogt AD and Di Cera E (2012) Conformational selection or induced fit? A critical appraisal of the kinetic mechanism. Biochemistry 51:5894-5902.
21. Yamashita A, Singh SK, Kawate T, Jin Y, and Gouaux E (2005) Crystal structure of a bacterial homologue of Na+/Cl-dependent neurotransmitter transporters. Nature 437:215-223.
22. Zhou Z, Zhen J, Karpowich NK, Goetz RM, Law CJ, Reith ME, and Wang DN (2007) LeuT-desipramine structure reveals how antidepressants block neurotransmitter reuptake. Science 317:1390-1393.